Differential Impact of Smoking on Methylome and Transcriptome in Crohn's Disease and Ulcerative Colitis

被引:2
作者
Ang, Qi Yan
Plichta, Damian [1 ]
Kim, Sean [2 ]
Kim, Iris Hyun-A
Gregory, Sadie
Xia, Yan [1 ]
Lau, Helena [2 ]
Xavier, Ramnik [1 ,2 ,3 ,4 ]
Ananthakrishnan, Ashwin N. [2 ,3 ,5 ]
机构
[1] Broad Inst, Cambridge, MA USA
[2] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA
[3] Harvard Med Sch, Boston, MA USA
[4] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA USA
[5] Massachusetts Gen Hosp, Crohns & Colitis Ctr, 165 Cambridge St, Boston, MA 02114 USA
基金
美国国家卫生研究院;
关键词
Crohn's disease; ulcerative colitis; smoking; epigenetics; RNA-seq; methylation; INFLAMMATORY-BOWEL-DISEASE; CIGARETTE-SMOKING; RISK-FACTORS; POLYMORPHISMS; METHYLATION; EXPRESSION; SIGNATURES; MIGRATION; PACKAGE;
D O I
10.1093/ibd/izad268
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Smoking is an environmental factor that differentially impacts Crohn's disease (CD) and ulcerative colitis (UC). The mechanism of impact of smoking on disease risk and clinical outcomes remains to be established.Methods This study used a prospective cohort of patients with CD or UC. Self-reported smoking status was validated using serum cotinine measurement. We profiled methylation changes in peripheral blood using the Illumina Methylation BeadChip. Transcriptomic profiling was performed on ileal and colonic tissue using an Illumina TruSeq platform. We compared the methylation and transcriptional changes in current, former, and never smokers stratified by disease type.Results Our cohort included 200 patients with CD or UC with methylation profiles and 160 with transcriptomic data. The mean serum cotinine level was higher in current compared with former or never smokers. Epigenetic changes common to both CD and UC included hypomethylation at AHRR. Smoking-associated MGAT3 hypomethylation was associated with severe disease course only in UC, while IER3 hypomethylation was associated with worse course only in CD. Smoking downregulated several inflammatory pathways in UC. Current smoking in CD but not in UC was associated with upregulation of several genes mediating Paneth cell function. Genes with opposite direction of effects in CD and UC include HSD3B2 and GSTA1.Conclusions Our findings suggest both common and differential effects of cigarette smoking on CD and UC. Paneth cell dysfunction may mediate adverse impact of smoking on CD. Bile acid and oxidative stress pathways may be relevant for the differential effect of smoking on CD and UC. Smoking is a key environmental risk factor for the development of inflammatory bowel disease. Smoking induces changes differential epigenetic changes in the peripheral blood in Crohn's disease and ulcerative colitis. Smoking also induces down regulation of expression of various proinflammatory genes in the colon in ulcerative colitis.
引用
收藏
页码:981 / 991
页数:11
相关论文
共 50 条
  • [41] Diagnosis of Crohn’s disease and ulcerative colitis using the microbiome
    Da-Yeon Kang
    Jong-Lyul Park
    Min-Kyung Yeo
    Sang-Bum Kang
    Jin-Man Kim
    Ju Seok Kim
    Seon-Young Kim
    BMC Microbiology, 23
  • [42] Safety of vedolizumab in the treatment of Crohn's disease and ulcerative colitis
    Hagan, Matilda
    Cross, Raymond K.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (09) : 1473 - 1479
  • [43] Crohn's Disease after Proctocolectomy and IPAA for Ulcerative Colitis
    Hercun, Julian
    Cote-Daigneault, Justin
    Lahaie, Raymond G.
    Richard, Carole
    Wassef, Ramses
    Poitras, Pierre
    DISEASES OF THE COLON & RECTUM, 2021, 64 (02) : 217 - 224
  • [44] Fracture risk is increased in Crohn's disease, but not in ulcerative colitis
    Vestergaard, P
    Krogh, K
    Rejnmark, L
    Laurberg, S
    Mosekilde, L
    GUT, 2000, 46 (02) : 176 - 181
  • [45] Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis
    Vilela, Eduardo Garcia
    da Gama Torres, Henrique Osvaldo
    Martins, Fabiana Paiva
    de Abreu Ferrari, Maria de Lourdes
    Andrade, Marcella Menezes
    da Cunha, Aloisio Sales
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (09) : 872 - 881
  • [46] Measures of Obesity and Risk of Crohn's Disease and Ulcerative Colitis
    Khalili, Hamed
    Ananthakrishnan, Ashwin N.
    Konijeti, Gauree G.
    Higuchi, Leslie M.
    Fuchs, Charles S.
    Richter, James M.
    Chan, Andrew T.
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (02) : 361 - 368
  • [47] Is there a role for vedolizumab in the treatment of ulcerative colitis and Crohn's disease?
    Gilroy, Leah
    Allen, Patrick B.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2014, 7 : 163 - 172
  • [48] Differentially Expressed miRNAs in Ulcerative Colitis and Crohn's Disease
    Yarani, Reza
    Shojaeian, Ali
    Palasca, Oana
    Doncheva, Nadezhda T.
    Jensen, Lars Juhl
    Gorodkin, Jan
    Pociot, Flemming
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [49] Historical Perspectives: Malignancy in Crohn's Disease and Ulcerative Colitis
    Williams, Hannah
    Steinhagen, Randolph M.
    CLINICS IN COLON AND RECTAL SURGERY, 2024, 37 (01) : 5 - 12
  • [50] Existing dietary guidelines for Crohn's disease and ulcerative colitis
    Brown, Amy C.
    Rampertab, S. Devi
    Mullin, Gerard E.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 5 (03) : 411 - 425